Clinical Trial Update: Clinical Trial Using Humira in Netherton Syndrome [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial evaluating adalimumab (Humira) for Netherton syndrome, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Netherton Syndrome | Phase 2 | Status: COMPLETED